{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:19:20Z","timestamp":1784542760359,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T00:00:00Z","timestamp":1599523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003744","name":"Stiftelsen Handlanden Hjalmar Svenssons","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003744","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ygyno.2020.09.004","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T05:39:12Z","timestamp":1600148352000},"page":"409-417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Increased disease-free and relative survival in advanced ovarian cancer after centralized primary treatment"],"prefix":"10.1016","volume":"159","author":[{"given":"Charlotte","family":"Palmqvist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Staf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantina","family":"Mateoiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Albertsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernilla","family":"Dahm-K\u00e4hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ygyno.2020.09.004_bb0005","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.bulcan.2016.09.013","article-title":"Surgical management of ovarian cancer: trends in clinical practice","volume":"103","author":"Querleu","year":"2016","journal-title":"Bull. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2020.09.004_bb0010","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/AOG.0000000000002164","article-title":"Association of hospital volume and quality of care with survival for ovarian cancer","volume":"130","author":"Wright","year":"2017","journal-title":"Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.ygyno.2020.09.004_bb0015","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"du Bois","year":"2009","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.004_bb0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.AOG.0000192407.04428.bb","article-title":"Aggressive surgical effort and improved survival in advanced-stage ovarian cancer","volume":"107","author":"Aletti","year":"2006","journal-title":"Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.ygyno.2020.09.004_bb0025","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.004_bb0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ygyno.2017.11.009","article-title":"Centralization of ovarian cancer in the Netherlands: hospital of diagnosis no longer determines patients\u2019 probability of undergoing surgery","volume":"148","author":"Timmermans","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2020.09.004_bb0035","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ygyno.2019.05.016","article-title":"Impact of hospital surgical volume on complete gross resection (CGR) rates following primary debulking surgery for advanced stage epithelial ovarian carcinoma","volume":"154","author":"Nasioudis","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2020.09.004_bb0040","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ygyno.2017.03.020","article-title":"Trends and factors associated with radical cytoreductive surgery in the United States: a case for centralized care","volume":"145","author":"Sinno","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2020.09.004_bb0045","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ygyno.2016.04.012","article-title":"Improved outcomes due to changes in organization of care for patients with ovarian cancer in the Netherlands","volume":"141","author":"Eggink","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2020.09.004_bb0050","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ygyno.2016.05.025","article-title":"Centralized primary care of advanced ovarian cancer improves complete cytoreduction and survival \u2013 a population-based cohort study","volume":"142","author":"Dahm-Kahler","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2020.09.004_bb0055","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/0284186X.2017.1366048","article-title":"Data quality in the Swedish quality register of gynecologic cancer \u2013 a Swedish Gynecologic Cancer Group (SweGCG) study","volume":"57","author":"Rosenberg","year":"2018","journal-title":"Acta Oncol."},{"key":"10.1016\/j.ygyno.2020.09.004_bb0060","first-page":"101","article-title":"The relative survival rate: a statistical methodology","volume":"6","author":"Ederer","year":"1961","journal-title":"Natl. Cancer Inst. Monogr."},{"issue":"3","key":"10.1016\/j.ygyno.2020.09.004_bb0065","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/biom.12477","article-title":"A log-rank-type test to compare net survival distributions","volume":"72","author":"Graff\u00e9o","year":"2016","journal-title":"Biometrics"},{"issue":"4","key":"10.1016\/j.ygyno.2020.09.004_bb0070","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2307\/2530964","article-title":"A cox regression model for the relative mortality and its application to diabetes mellitus survival data","volume":"41","author":"Andersen","year":"1985","journal-title":"Biometrics"},{"issue":"4","key":"10.1016\/j.ygyno.2020.09.004_bb0075","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1214\/aos\/1176345976","article-title":"Cox\u2019s regression model for counting processes: a large sample study","volume":"10","author":"Andersen","year":"1982","journal-title":"Ann. Stat."},{"issue":"3","key":"10.1016\/j.ygyno.2020.09.004_bb0080","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"issue":"24","key":"10.1016\/j.ygyno.2020.09.004_bb0085","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1002\/sim.2414","article-title":"Goodness of fit of relative survival models","volume":"24","author":"Stare","year":"2005","journal-title":"Stat. Med."},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.004_bb0090","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ygyno.2017.07.136","article-title":"Survival and safety associated with aggressive surgery for stage III\/IV epithelial ovarian cancer: a single institution observation study","volume":"147","author":"Tate","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.004_bb0095","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ygyno.2018.08.014","article-title":"Continuous improvement in primary Debulking surgery for advanced ovarian cancer: do increased complete gross resection rates independently lead to increased progression-free and overall survival?","volume":"151","author":"Tseng","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2020.09.004_bb0100","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ygyno.2016.01.008","article-title":"Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center","volume":"140","author":"Mueller","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.09.004_bb0105","article-title":"Optimal primary surgical treatment for advanced epithelial ovarian cancer","volume":"8","author":"Elattar","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"10.1016\/j.ygyno.2020.09.004_bb0110","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.004_bb0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2013.07.086","article-title":"The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma \u2013 analysis of patient data in the prospective OVCAD study","volume":"131","author":"Hofstetter","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.09.004_bb0120","author":"Regionala Cancer Centrum i Samverkan"},{"issue":"3","key":"10.1016\/j.ygyno.2020.09.004_bb0125","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ygyno.2009.08.025","article-title":"Impact of surgeon and hospital ovarian cancer surgical case volume on in-hospital mortality and related short-term outcomes","volume":"115","author":"Bristow","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.09.004_bb0130","series-title":"\u00c4ggstockscancer \u2013 Nationellt V\u00e5rdprogram","author":"Regionala Cancer Centrum i Samverkan","year":"2014"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582033897X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582033897X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T08:06:03Z","timestamp":1715846763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082582033897X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S009082582033897X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.09.004","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased disease-free and relative survival in advanced ovarian cancer after centralized primary treatment","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}